Blood Thinners recalls

The FDA has published 156 recalls involving blood thinners since 2012. The latest was reported on 5 Aug 2026. Most were for sterility. Central Admixture Pharmacy Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls156since 2012

Last 12 months5reported

Class I2919% of total

Ongoing14latest 5 Aug 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 2 0Jan '25 0 0 0Apr 0 0 0Jul 0 1 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 2Jul 3 0

Severity split

Class I 29 19%Class II 120 77%Class III 7 4%

Why blood thinners is recalled

Companies

Brands

By year

202653%
202511%
202464%
20235636%
202164%
202064%
2019138%
201874%
201732%
201685%

Ongoing blood thinners recalls

14 active

Reported	Class	Recall	Company	Reason	Where
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 110 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
3 Sep 2025Drug	CLASS II	Enoxaparin Sodium Injection, USP, 30 mg recalled by Cardinal HealthEnoxaparin Sodium	Cardinal Health	Packaging Defects	KS

All blood thinners recalls, newest first

156 total

Reported	Class	Recall	Company	Reason	Where
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 110 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
3 Sep 2025Drug	CLASS II	Enoxaparin Sodium Injection, USP, 30 mg recalled by Cardinal HealthEnoxaparin Sodium	Cardinal Health	Packaging Defects	KS
18 Dec 2024Drug	CLASS II	Dabigatran Etexilate recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
18 Dec 2024Drug	CLASS II	Dabigatran Etexilate, 150mg capsules recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
11 Sep 2024Drug	CLASS I	Heparin (Heparin Sodium in 9% Sodium Chloride Injection) recalledHeparin Sodium In Sodium Chloride	Baxter Healthcare	Sterility	Nationwide
3 Jan 2024Drug	CLASS II	Warfarin Sodium Tablets, USP, 5 mg recalled by Cardinal HealthcareWarfarin Sodium	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Blood Thinners?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.